Free Trial
OTCMKTS:NRIFF

Nuvo Pharmaceuticals (NRIFF) Stock Price, News & Analysis

About Nuvo Pharmaceuticals Stock (OTCMKTS:NRIFF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
7,337 shs
Market Capitalization
$8.52 million
P/E Ratio
18.69
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NRIFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRIFF Stock News Headlines

4 Best Home Oxygen Concentrators Of 2024
See More Headlines

NRIFF Stock Analysis - Frequently Asked Questions

Shares of NRIFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:NRIFF
CIK
N/A
Fax
N/A
Employees
99
Year Founded
N/A

Profitability

Trailing P/E Ratio
18.69
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$52.41 million
Price / Cash Flow
0.82
Book Value
$1.59 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.52 million
Optionable
Not Optionable
Beta
1.57
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:NRIFF) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners